ATI RN
Cardiovascular System Practice Exam
1. What is the condition where the lung collapses due to air leaking into the space between the lung and chest wall?
- A. Pneumothorax
- B. Pleural effusion
- C. Pulmonary fibrosis
- D. Lung cancer
Correct answer: A
Rationale: Pneumothorax is the correct answer. It is the collapse of a lung due to air leaking into the space between the lung and chest wall. This condition often requires emergency treatment. Choice B, Pleural effusion, is the buildup of excess fluid between the layers of the pleura outside the lung, not air. Choice C, Pulmonary fibrosis, is a lung disease characterized by scarring and thickening of lung tissue, not related to lung collapse. Choice D, Lung cancer, is the uncontrolled growth of abnormal cells in the lung, not directly causing lung collapse.
2. Which procedure is used to remove excess fluid or air from the pleural space, helping to relieve pressure on the lungs?
- A. Thoracentesis
- B. Bronchoscopy
- C. Chest X-ray
- D. Arterial blood gas (ABG)
Correct answer: A
Rationale: The correct answer is Thoracentesis. Thoracentesis is a procedure specifically designed to remove excess fluid or air from the pleural space in the chest. This process helps to relieve pressure on the lungs and improve breathing. Bronchoscopy (Choice B) is a procedure used to visualize the airways and diagnose lung conditions, not to remove fluid from the pleural space. Chest X-ray (Choice C) is an imaging test that provides a picture of the structures inside the chest, including the lungs, heart, and bones. Arterial blood gas (ABG) test (Choice D) is a blood test that measures the levels of oxygen and carbon dioxide in the blood, providing information about how well the lungs are working, but it does not involve removing excess fluid or air from the pleural space.
3. Which condition involves the enlargement and weakening of the left ventricle of the heart, leading to reduced pumping ability?
- A. Dilated cardiomyopathy
- B. Hypertrophic cardiomyopathy
- C. Restrictive cardiomyopathy
- D. Pericarditis
Correct answer: A
Rationale: The correct answer is A: Dilated cardiomyopathy. Dilated cardiomyopathy is characterized by the enlargement and weakening of the left ventricle of the heart, which results in a reduced ability to pump blood effectively. Choice B, Hypertrophic cardiomyopathy, involves thickening of the heart muscle, not enlargement. Choice C, Restrictive cardiomyopathy, is characterized by stiffening of the heart muscle, not enlargement. Choice D, Pericarditis, refers to inflammation of the pericardium, the lining surrounding the heart, and does not involve enlargement and weakening of the left ventricle.
4. What is a condition where the heart beats too slowly, reducing the amount of blood pumped to the body?
- A. Bradycardia
- B. Tachycardia
- C. Atrial fibrillation
- D. Ventricular fibrillation
Correct answer: A
Rationale: Bradycardia is the correct answer. It is a condition characterized by a slow heart rate, which reduces the amount of blood pumped to the body. This can lead to symptoms like fatigue and dizziness. Choice B, Tachycardia, is the opposite condition where the heart beats too fast. Choices C and D, Atrial fibrillation and Ventricular fibrillation, refer to irregular and potentially life-threatening rapid heart rhythms involving the atria and ventricles respectively, not a slow heart rate.
5. A client on spironolactone (Aldactone) has a potassium level of 6.0 mEq/L. What is the nurse’s priority action?
- A. Hold the spironolactone and notify the healthcare provider.
- B. Administer a potassium supplement.
- C. Continue the spironolactone as ordered.
- D. Increase the dose of spironolactone.
Correct answer: A
Rationale: The correct action for a client on spironolactone with a potassium level of 6.0 mEq/L is to hold the medication and notify the healthcare provider. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels, which are already high. Administering a potassium supplement (Choice B) would exacerbate the hyperkalemia. Continuing the spironolactone as ordered (Choice C) could lead to worsening hyperkalemia. Increasing the dose of spironolactone (Choice D) would be contraindicated in the presence of elevated potassium levels.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access